Systemic Administration of Mesenchymal Stem Cells Increases Neuron Survival after Global Cerebral Ischemia In Vivo (2VO)
Open Access
- 19 December 2010
- journal article
- research article
- Published by Hindawi Limited in Neural Plasticity
- Vol. 2010, 1-5
Abstract
Although many studies have shown that administration of stem cells after focal cerebral ischemia improves brain damage, very little data are available concerning the damage induced by global cerebral ischemia. The latter causes neuronal death in selectively vulnerable areas, including the hippocampal CA1 region. We tested the hypothesis that intravenous infusion of bone marrowderived stromal cells (mesenchimal stem cells, MSC) reduce brain damage after transient global ischemia. In adult male Sprague-Dawley rats transient global ischemia was induced using bilateral common carotid artery occlusion for 20 min in addition to controlled hypotension. Five days after, the animals were anaesthetized with urethane and the brain was fixed, sectioned and stained with hematoxylin-eosin to investigate histological damage. MSC did not fully protect against ischemic damage, as the number of viable neurons in this group was lower than in normal (sham-operated) rats. However, in MSC-treated rats the number of viable CA1 pyramidal neurons was significally higher than in rats that had been subjected to ischemia but not treated with MSC. We conclude that intravenous administration of MSC after transient global ischemia reduces hippocampal damage.Keywords
This publication has 27 references indexed in Scilit:
- Neuroprotective mesenchymal stem cells are endowed with a potent antioxidant effect in vivoJournal of Neurochemistry, 2009
- Intracerebroventricular administration of creatine protects against damage by global cerebral ischemia in ratBrain Research, 2006
- Correlation Among Pathology, Genotype, and Patient Outcomes in GlioblastomaJournal of Neuropathology & Experimental Neurology, 2006
- Human stem/progenitor cells from bone marrow promote neurogenesis of endogenous neural stem cells in the hippocampus of miceProceedings of the National Academy of Sciences, 2005
- Mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis inducing T-cell anergyBlood, 2005
- Autologous mesenchymal stem cell transplantation in stroke patientsAnnals of Neurology, 2005
- Expression of insulin-like growth factor 1 and receptor in ischemic rats treated with human marrow stromal cellsBrain Research, 2004
- Targeting of marrow-derived astrocytes to the ischemic brainNeuroReport, 1999
- Stem Cells in the Central Nervous SystemScience, 1997
- Global Brain Ischemia and ReperfusionAnnals of Emergency Medicine, 1996